Drug allergy passport advised for patients with hypersensitivity

Drug allergy passport advised for patients with hypersensitivity

(HealthDay)—A drug allergy passport, providing information on culprit drugs, clinical manifestations, and alternate drugs to prescribe, should be provided to patients with drug hypersensitivity, according to a position paper published online May 4 in Allergy.

Noting that proper documentation is essential for doctors to make correct therapeutic decisions, Knut Brochow, M.D., from the Technical University Munich in Germany, and colleagues developed a allergy passport, as well as guidelines for drug allergy documentation for recording drug hypersensitivity.

The authors note that a drug allergy passport, drug allergy alert card, certificate, and discharge letter after medical evaluation are sufficient for documenting drug hypersensitivity. Patients should be advised to carry the documentation at all times and especially when they are away from home. Information on culprit drugs (including international non-proprietary name), clinical manifestations, diagnostic measures, potential cross-reactivity, alternate drugs to prescribe, and where more detailed can be obtained should be included in the drug allergy passport. The passport should be provided to after a full allergy work-up.

"In the future, electronic prescription systems with alert functions will become more common and should include the same information as in paper-based documentation," the authors write.


Explore further

Take two aspirin and make sure you're not allergic

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Allergy

Copyright © 2016 HealthDay. All rights reserved.

Citation: Drug allergy passport advised for patients with hypersensitivity (2016, May 10) retrieved 26 February 2020 from https://medicalxpress.com/news/2016-05-drug-allergy-passport-patients-hypersensitivity.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
18 shares

Feedback to editors

User comments